» Articles » PMID: 36216935

The Burden of Proof Studies: Assessing the Evidence of Risk

Abstract

Exposure to risks throughout life results in a wide variety of outcomes. Objectively judging the relative impact of these risks on personal and population health is fundamental to individual survival and societal prosperity. Existing mechanisms to quantify and rank the magnitude of these myriad effects and the uncertainty in their estimation are largely subjective, leaving room for interpretation that can fuel academic controversy and add to confusion when communicating risk. We present a new suite of meta-analyses-termed the Burden of Proof studies-designed specifically to help evaluate these methodological issues objectively and quantitatively. Through this data-driven approach that complements existing systems, including GRADE and Cochrane Reviews, we aim to aggregate evidence across multiple studies and enable a quantitative comparison of risk-outcome pairs. We introduce the burden of proof risk function (BPRF), which estimates the level of risk closest to the null hypothesis that is consistent with available data. Here we illustrate the BPRF methodology for the evaluation of four exemplar risk-outcome pairs: smoking and lung cancer, systolic blood pressure and ischemic heart disease, vegetable consumption and ischemic heart disease, and unprocessed red meat consumption and ischemic heart disease. The strength of evidence for each relationship is assessed by computing and summarizing the BPRF, and then translating the summary to a simple star rating. The Burden of Proof methodology provides a consistent way to understand, evaluate and summarize evidence of risk across different risk-outcome pairs, and informs risk analysis conducted as part of the Global Burden of Diseases, Injuries, and Risk Factors Study.

Citing Articles

Trading species to extinction: evidence of extinction linked to the wildlife trade.

Hinsley A, Willis J, Dent A, Oyanedel R, Kubo T, Challender D Camb Prism Extinct. 2025; 1:e10.

PMID: 40078683 PMC: 11895731. DOI: 10.1017/ext.2023.7.


Changing life expectancy in European countries 1990-2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021.

Lancet Public Health. 2025; 10(3):e172-e188.

PMID: 39983748 PMC: 11876102. DOI: 10.1016/S2468-2667(25)00009-X.


The global burden of disease study and Population Health Metrics.

Wyper G Popul Health Metr. 2024; 22(1):35.

PMID: 39673070 PMC: 11639115. DOI: 10.1186/s12963-024-00357-7.


The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024; 404(10469):2314-2340.

PMID: 39645376 PMC: 11694014. DOI: 10.1016/S0140-6736(24)01446-6.


National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050.

Lancet. 2024; 404(10469):2278-2298.

PMID: 39551059 PMC: 11694015. DOI: 10.1016/S0140-6736(24)01548-4.


References
1.
Murray C, Lopez A . Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349(9063):1436-42. DOI: 10.1016/S0140-6736(96)07495-8. View

2.
Murray C, Ezzati M, Lopez A, Rodgers A, Vander Hoorn S . Comparative quantification of health risks conceptual framework and methodological issues. Popul Health Metr. 2003; 1(1):1. PMC: 156894. DOI: 10.1186/1478-7954-1-1. View

3.
Stanley K . Evaluation of randomized controlled trials. Circulation. 2007; 115(13):1819-22. DOI: 10.1161/CIRCULATIONAHA.106.618603. View

4.
Deaton A, Cartwright N . Understanding and misunderstanding randomized controlled trials. Soc Sci Med. 2018; 210:2-21. PMC: 6019115. DOI: 10.1016/j.socscimed.2017.12.005. View

5.
Chouinard E, Walter S . Recall bias in case-control studies: an empirical analysis and theoretical framework. J Clin Epidemiol. 1995; 48(2):245-54. DOI: 10.1016/0895-4356(94)00132-a. View